From Monday, 26.08.24, price increases for hundreds of pharmaceuticals will come into force, as announced by the Greek Ministry of Health.
The increase for all drugs was 35%, with the increase affecting 580 drugs, including antibiotics and insulin. The revaluation concerns cheap drugs so that they are not withdrawn from the Greek market.
The list includes the most common drugs. A typical example is the increase in the antibiotic Augmentin, the price of which increases from 5.94 to 7.48. In addition, the paracetamol drug Apotel will now cost 5.61 euros instead of 3.85 euros previously.
The cost of the revaluation is estimated at approximately €30 million for patients (in addition to their co-payment for the prescribed drug), with the cost share of EOPYY being approximately €60 million.
More Stories
Medicines: rising costs for citizens
BRICS and G7: New Energy Race and Struggle for Resources
AADE Prepares Digital Client List for Freelancers – Who Does It Concern?